NY-ESTÉE-LAUDER
5.4.2024 15:26:35 CEST | Business Wire | Press release
TOM FORD announced today that Dexter King has been appointed Senior Vice President, Global General Manager, TOM FORD BEAUTY. King will step into this role effective April 1, 2024 and continue reporting to Guillaume Jesel, President and CEO, TOM FORD and Luxury Business Development, The Estée Lauder Companies. King will also join The Estée Lauder Companies (NYSE:EL) Extended Executive Leadership Team.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240405576513/en/
Dexter King has been appointed Senior Vice President, Global General Manager, TOM FORD BEAUTY. (Photo: Business Wire)
King has been with TOM FORD BEAUTY for nine years, working in a number of key leadership roles including most recently as Senior Vice President (SVP), Global Marketing and Strategy, and prior to then as SVP, General Manager, International and Global Strategy. In close partnership with Jesel, under King’s leadership of strategy and International, the brand elevated key TOM FORD fragrances to the luxury tier, accelerated its channel strategy and achieved exceptional growth and share gains across key markets.
“Dexter’s multi-faceted leadership experience at TOM FORD BEAUTY has been instrumental in helping the brand achieve exceptional global growth,” said Jesel. “His deep understanding of luxury, the importance of aspirational local relevance, and his command of the strategic growth opportunities in the luxury sector make him well-suited to lead the continued global momentum of TOM FORD BEAUTY.”
In his new role, King will lead the TOM FORD BEAUTY team in all aspects of category, channel and geography strategic growth plans. He will focus on driving the brand’s luxury beauty positioning through world-class innovation across makeup, fragrance and skincare and continue to elevate the brand’s signature aspirational storytelling of modern luxury glamour and amplifying individual beauty.
Prior to TOM FORD BEAUTY, King worked in strategy and marketing roles, holding positions of increasing responsibility across companies including McKinsey & Company, Diageo, and Moët Hennessy. King holds a Master of Business Administration from The Fuqua School of Business at Duke University and a Bachelor of Arts in Economics from the University of Virginia.
About TOM FORD
TOM FORD IS A GLOBAL DESIGN HOUSE OFFERING EXCEPTIONAL LUXURY PRODUCTS ACROSS WOMEN’S AND MEN’S FASHION, ACCESSORIES, EYEWEAR AND BEAUTY. FOUNDED IN 2005 BY TOM FORD, TODAY THE BRAND HAS A PRESENCE IN MORE THAN 100 MARKETS GLOBALLY, AND IS WIDELY RECOGNIZED AS THE ARCHITECT OF LUXURY GLAMOUR. IN 2023, THE ESTÉE LAUDER COMPANIES BECAME THE SOLE OWNER OF THE TOM FORD BRAND AND ALL ITS INTELLECTUAL PROPERTY. IN APRIL 2023 PETER HAWKINGS WAS APPOINTED THE CREATIVE DIRECTOR OF TOM FORD.
About TOM FORD BEAUTY
TOM FORD IS A GLOBAL DESIGN HOUSE OFFERING EXCEPTIONAL LUXURY PRODUCTS ACROSS WOMEN’S AND MEN’S FASHION, ACCESSORIES, EYEWEAR AND BEAUTY. FOUNDED IN 2005 BY TOM FORD, TODAY THE BRAND HAS A PRESENCE IN MORE THAN 100 MARKETS GLOBALLY, AND IS WIDELY RECOGNIZED AS THE ARCHITECT OF LUXURY GLAMOUR. TOM FORD BEAUTY IS DESIGNED TO AMPLIFY INDIVIDUAL BEAUTY WITH A COLLECTION OF SUMPTUOUS COSMETICS, EXTRAORDINARY FRAGRANCES AND ADVANCED SKINCARE.
ELC-B
NYSE: EL
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240405576513/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Arboris Capital Selects ROYC to Expand Private Markets Capabilities on CapGain Platform18.5.2026 09:00:00 CEST | Press release
Arboris Capital Limited (“Arboris”), a DIFC-based firm arranging alternative investments, authorised by the Dubai Financial Services Authority (DFSA), today announced that it has selected ROYC AB (“ROYC”), a private markets technology and infrastructure provider, to support the continued development of its private markets offering through its platform, CapGain. In its ongoing efforts to expand its private markets capabilities across the Middle East, Arboris has undertaken a strategic review of how to further scale its offering while maintaining the integrity of its existing platform. As a result, Arboris has chosen to integrate ROYC’s fund access, sourcing, and structuring capabilities into CapGain, complementing its existing infrastructure. CapGain is Arboris’s proprietary investment platform, purpose-built to facilitate access between international private market opportunities and Professional Investors in the region. CapGain provides fully digital investor onboarding and KYC, a secu
OdysseyRe Announces New Co-Chief Underwriting Officers for EMEA18.5.2026 09:00:00 CEST | Press release
Odyssey Reinsurance Company (OdysseyRe) today announced the appointments of Tegwen Gromellon and Anne-Claire Serres as co-chief underwriting officers of its EMEA division, effective July 1. They succeed longtime Chief Underwriting Officer, Gaël Le Païh, who is retiring later this year following 36 years with the Company. Based in Paris, Serres joined OdysseyRe in 2018 as the market director for France and will lead the division’s business across France, Africa and the Middle East. Gromellon, who joined OdysseyRe in 2004, has served as market director for Germany, Austria, Benelux and Switzerland since 2019. He will take the lead for the rest of Europe, including the relationship with the Company’s representative office in Stockholm for the Nordic markets and across Turkey. “We are delighted to appoint both Tegwen and Anne-Claire to these important leadership positions,” said Isabelle Dubots-Lafitte, chief executive officer of EMEA for OdysseyRe. “These appointments recognize their sign
LogicMonitor and Deutsche Telekom Expand Partnership Across Europe18.5.2026 09:00:00 CEST | Press release
Expanded availability of LogicMonitor within Deutsche Telekom’s managed services portfolio follows successful operational use in the UKSelect outcomes include reduced reporting times and proactive incident preventionExpansion extends across DACH, Benelux, and the Nordics LogicMonitor®, the AI-first platform for Autonomous IT, today announced the expanded availability of its platform within Deutsche Telekom’s managed services portfolio across selected European markets, including DACH, Benelux, and the Nordics. The expansion builds on operational use of LogicMonitor in the United Kingdom since 2023, where it has supported Deutsche Telekom’s service teams in improving visibility across network, cloud, and hybrid infrastructure environments. Experience gained from these deployments is now informing broader service enablement across additional European markets. As enterprise IT environments grow more complex, organisations require more than visibility—they need predictive resilience. Throug
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy18.5.2026 09:00:00 CEST | Press release
ZH9 is very well tolerated with a favourable safety profile, and no dose-limiting toxicities or Grade ≥3 drug-related adverse events reported.ZH9 demonstrates 91% freedom-from-relapse in NMIBC patients who have reached study end.Company plans to run a larger phase 2 study across a range of patient populations spanning intermediate risk and high risk including CIS. Prokarium, a clinical-stage biopharmaceutical company pioneering bacterial immunotherapies for the treatment of solid tumours, today announced safety and antitumour efficacy results from an interim review of the ongoing Phase 1/1b PARADIGM-1 trial of ZH9 in non-muscle invasive bladder cancer (NMIBC) patients. These data were shared via an oral podium presentation at the American Urology Association (AUA26) Annual Meeting. Prokarium CMO, Dr Josefin-Beate Holz said “These data demonstrate ZH9 as a universally applicable treatment for patients. As the treatment is very well tolerated and is showing impactful outcomes for early a
VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer18.5.2026 08:00:00 CEST | Press release
Endotronix co-founder and former CEO joins VahatiCor as the company advances the A-FLUX Reducer System® and the SERRA-I early feasibility study VahatiCor, Inc., a medtech company developing interventional therapies for Coronary Microvascular Dysfunction (CMD), announced today the appointment of Harry D. Rowland, Ph.D., as Chief Executive Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260517830314/en/ VahatiCor CEO, Harry D. Rowland, Ph.D. Rowland previously served as Chief Executive Officer and President of Endotronix, where he led the development and commercialization of the Cordella™ Pulmonary Artery Sensor and Heart Failure System. Under his leadership, Endotronix raised over $150 million and grew to more than 150 employees. He also oversaw the PROACTIVE-HF pivotal trial from execution through FDA premarket approval and commercial launch. Following its acquisition by Edwards Lifesciences in 2024, Rowland stayed o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom